Literature DB >> 2398386

Treatment of spinal metastases from kidney cancer by presurgical embolization and resection.

N Sundaresan1, I S Choi, J E Hughes, V P Sachdev, A Berenstein.   

Abstract

Surgical treatment of bone metastases from kidney cancer is often complicated by profuse blood loss. The authors report the results of a retrospective review of 30 consecutive patients who underwent surgery for spinal metastases from kidney cancer. Seventeen patients (57%) were operated on after failing radiation therapy. Prior to operation, selective spinal angiography and embolization were performed in 17 patients with no permanent neurological deficits resulting. Gross total resection of the tumor and stabilization of the spine were then accomplished with acceptable blood loss. Twenty-seven (90%) of the 30 patients improved neurologically following surgery. There was a median survival time of 16 months, a 2-year survival rate of 33%, and a 5-year survival rate of 15%. Major surgical complications in this series were related to excessive blood loss in patients without embolization. These data suggest that patients with spinal metastases from kidney cancer should undergo spinal angiography and embolization prior to resection of the tumor. To improve upon current results, such treatment should be carried out prior to external radiation therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2398386     DOI: 10.3171/jns.1990.73.4.0548

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

Review 1.  Management of metastatic sacral tumours.

Authors:  Nasir A Quraishi; Kyriakos E Giannoulis; Kimberley L Edwards; Bronek M Boszczyk
Journal:  Eur Spine J       Date:  2012-06-23       Impact factor: 3.134

2.  Spinal cord infarction complicating embolisation of vertebral metastasis: a result of masking of a spinal artery by a high-flow lesion.

Authors:  H J Cloft; M E Jensen; H M Do; D F Kallmes
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

3.  Preoperative transarterial embolization of spinal tumor: embolization techniques and results.

Authors:  H B Shi; D C Suh; H K Lee; S M Lim; D H Kim; C G Choi; C S Lee; S C Rhim
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

4.  Pre-operative embolisation of spinal metastasis: technique, complication rate and outcome-clinical experience.

Authors:  Patrick Cernoch; Lukas Hechelhammer; Alexander von Hessling; Christian Spross; Johannes Erhardt; Bernhard Jost; Fabrice A Külling
Journal:  Int Orthop       Date:  2015-04-29       Impact factor: 3.075

5.  Operative management of epidural tumors of the spine.

Authors:  J D Rompe; C Hopf; J Heine
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

6.  Outcome of embolised vascular metastatic renal cell tumours causing spinal cord compression.

Authors:  N A Quraishi; S Purushothamdas; S R Manoharan; G Arealis; R Lenthall; M P Grevitt
Journal:  Eur Spine J       Date:  2013-01-18       Impact factor: 3.134

7.  Surgical treatment of cauda equina compression as a result of metastatic tumours of the lumbo-sacral junction and sacrum.

Authors:  Nasir A Quraishi; K E Giannoulis; S R Manoharan; K L Edwards; B M Boszczyk
Journal:  Eur Spine J       Date:  2012-12-18       Impact factor: 3.134

8.  [Surgical management of vertebral column metastatic disease].

Authors:  K-D Schaser; I Melcher; T Mittlmeier; A Schulz; J H Seemann; N P Haas; A C Disch
Journal:  Unfallchirurg       Date:  2007-02       Impact factor: 1.000

9.  Complications in the management of metastatic spinal disease.

Authors:  Eilis Catherine Dunning; Joseph Simon Butler; Seamus Morris
Journal:  World J Orthop       Date:  2012-08-18

10.  Preoperative transarterial embolization of vertebral metastases.

Authors:  Raphael Guzman; Susan Dubach-Schwizer; Paul Heini; Karl-Olof Lovblad; Daniel Kalbermatten; Gerhard Schroth; Luca Remonda
Journal:  Eur Spine J       Date:  2004-09-16       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.